New mutations in malaria parasite behind preventive drug resistance: Study
LSHTM researchers have said new mutations that enhance resistance to a drug used to prevent malaria in pregnant women and children are already common in countries fighting the disease. Mutations in two genes in the parasite plasmodium falciparum offer resistance to sulfadoxine-pyrimethamine, but recently, mutations related to resistance were discovered in a third gene, pfgch1.